BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 13711411)

  • 21. [Studies on the drug resistance of enteric bacteria. 14. On artificial elimination of transmissible drug-resistance by means of acriflavine].
    KAMEDA M; HARADA K; SUZUKI M; MITSUHASHI S
    Nihon Saikingaku Zasshi; 1962 Mar; 17():171-5. PubMed ID: 14453413
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis and antimicrobial activity of 1-acyl-2-sulfanilylhydrazine and 1-acy1-2-(4-amino-1-naphthylsulfony1)hydrazine.
    TSUJI T; NAKATA T; UEDA T
    Chem Pharm Bull (Tokyo); 1962 Mar; 10():210-9. PubMed ID: 13922877
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the drug resistance of enteric bacteria. 9. Transmission of the drug-resistance factor between spheroplasts.
    KAWAKAMI M; OSAWA N; MITSUHASHI S
    Jpn J Exp Med; 1961 Aug; 31():259-66. PubMed ID: 14454568
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experimental studies on the effect of elkosin on the H2S splitting by Escherichia coli bacteria].
    TANNERT S
    Z Gesamte Inn Med; 1952 Nov; 7(22):1042-6. PubMed ID: 13039339
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the drug resistance of enteric bacteria. 5. Mechanisms of the transmission of drug resistance between Shigella and E. coli].
    HARADA K; KAMEDA M; SUZUKI M; MITSUHASHI S
    Nihon Saikingaku Zasshi; 1961 Jan; 16():6-16. PubMed ID: 13711413
    [No Abstract]   [Full Text] [Related]  

  • 26. A preliminary report--resistance and cross-resistance of Escherichia coli mutants to radiomimetic agents.
    GREENBERG J; MANDELL JD; WOODY PL
    Cancer Chemother Rep; 1961 Apr; 11():51-6. PubMed ID: 13708244
    [No Abstract]   [Full Text] [Related]  

  • 27. pH dependency in uptake of sulfonamides by bacteria.
    Büttner D; Büttner H
    Chemotherapy; 1980; 26(3):153-63. PubMed ID: 6988182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The electronic structures and pharmacological activities of sulfanilamide derivatives and carbonic anhydrase inhibitors with the same sulfonamide moiety.
    Yonezawa T; Muro I; Kato H; Kimura M
    Mol Pharmacol; 1969 Sep; 5(5):446-54. PubMed ID: 4898668
    [No Abstract]   [Full Text] [Related]  

  • 29. [Research on some biological characteristics of Escherichia coli strains selected by sudden development of resistance to streptomycin].
    MOUTOUSES K; PAPABASILEIOU I; PAPADOPOULOU N
    Delt Hell Mikrobiol Hygieinol Hetair; 1960; 5():134-40. PubMed ID: 13773331
    [No Abstract]   [Full Text] [Related]  

  • 30. Inactivity of pteroylglutamic acid and leucovorin in overcoming sulfonamide growth inhibition of Escherichia coli.
    ALIMCHANDANI HR; SREENIVASAN A
    J Bacteriol; 1957 Aug; 74(2):171-4. PubMed ID: 13475216
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the cobalt-resistance in Escherichia coli. I. Studies on the permeability of cell wall of cobalt-resistant and sensitive Escherichia coli to cobalt ion.
    KATAYAMA Y
    Jpn J Microbiol; 1960 Oct; 4():351-6. PubMed ID: 14454228
    [No Abstract]   [Full Text] [Related]  

  • 32. Transmissible drug-resistance factors and formation of multiple resistance.
    MITSUHASHI S; HARADA K
    Nature; 1962 Aug; 195():517-8. PubMed ID: 14474717
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on drug resistance of enteric bacteria. 11. Effect of protease and nucleic acid-splitting enzymes].
    HARADA K; KAMEDA M; SUZUKI M; HASHIMOTO H; MITSUHASHI S
    Nihon Saikingaku Zasshi; 1961 Sep; 16():823-6. PubMed ID: 13904520
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies on a new sulfonamide, 4-methoxy-6-sulfanilamidopyrimidine. I. Antibacterial activities in vitro and in vivo].
    OSHIMA Y; NAGASAKI S; TACHI Y
    Nihon Yakurigaku Zasshi; 1962 Jan; 58():50-8. PubMed ID: 14482510
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on induction of streptomycin resistance by streptomycin in Escherichia coli].
    LUECK H; RICKERL E
    Zentralbl Bakteriol; 1960 Mar; 178():25-42. PubMed ID: 13853721
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical-experimental studies on the problem of the sulfonamide combination principle using the sulfonamide combination SH 522-2 and comparative observations on other sulfonamides].
    KUEMMERLE HP; TRAUT H
    Chemotherapia (Basel); 1960; 1():167-74. PubMed ID: 14412520
    [No Abstract]   [Full Text] [Related]  

  • 37. [PHYSICO-CHEMICAL AND BACTERIOLOGICAL STUDIES OF N'-ACYLATED SULFONAMIDES].
    SEYDEL J; WEMPE E
    Arzneimittelforschung; 1964 Jun; 14():705-8. PubMed ID: 14249071
    [No Abstract]   [Full Text] [Related]  

  • 38. Biochemical studies of Escherichia coli isolated from cases of urinary tract infection and their sensitivity to sulpha drugs and antibiotics.
    DARBARI BS; SAXENA BP
    J Indian Med Assoc; 1961 Apr; 36():283-6. PubMed ID: 13719714
    [No Abstract]   [Full Text] [Related]  

  • 39. Some aspects of the action of sulfonamides; binding of S35 labeled sulfanilamide by Escherichia coli.
    KLOTZ IM; MELCHIOR JB
    Arch Biochem; 1949 Mar; 21(1):35-9. PubMed ID: 18113486
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison of four methods of testing sulfonamide sensitivity and the relation to clinical response in urinary tract infections.
    BURDETTE RI; PLANK LE; CLAPPER WE
    Antibiot Chemother (Northfield); 1955 Jul; 5(7):392-7. PubMed ID: 24543673
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.